Objectives
Data sources
Methods
Results
Conclusions
Keywords
Introduction
- Regensteiner J.G.
- Hiatt W.R.
- Coll J.R.
- Criqui M.H.
- TreatJacobson D.
- McDermott M.M.
- et al.
National Institute for Health and Care Excellence. NICE Peripheral arterial disease quality standard 2014. Retrieved June 12, 2016, from https://www.nice.org.uk/guidance/qs52/resources/peripheral-arterial-disease-20987238166458.
Methods
Department of Health, Diabetes UK. Structured patient education in diabetes: Report from the Patient Education Working Group 2005. Retrieved October 10, 2016, from https://www.diabetes.org.uk/Documents/Reports/StructuredPatientEd.pdf.
Eligibility criteria
Outcomes
Information sources, search strategy, study records, and data management
Department of Health, Diabetes UK. Structured patient education in diabetes: Report from the Patient Education Working Group 2005. Retrieved October 10, 2016, from https://www.diabetes.org.uk/Documents/Reports/StructuredPatientEd.pdf.
Department of Health, Diabetes UK. Structured patient education in diabetes: Report from the Patient Education Working Group 2005. Retrieved October 10, 2016, from https://www.diabetes.org.uk/Documents/Reports/StructuredPatientEd.pdf.
Data collection processes
Cochrane Consumers and Communication Review Group. Communication review group: Data extraction template for Cochrane reviews. Cochrane Collaboration, 2007 (Updated Dec 2016). http://cccrg.cochrane.org/author-resources. [Accessed 10 May 2017].
Noyes J, Lewin S. Extracting qualitative evidence. In: Noyes J, Booth A, Hannes K, Harden A, Harris J, Lewin S, Lockwood C (Eds.), Supplementary guidance for inclusion of qualitative research in Cochrane systematic reviews of interventions, Chapter 5. Version 1 (updated August 2011). Cochrane Collaboration Qualitative Methods Group, 2011. Retrieved April 27, 2017, from http://cqrmg.cochrane.org/supplemental-handbook-guidance.
- Moher D.
- Shamseer L.
- Clarke M.
- Ghersi D.
- Liberati A.
- Petticrew M.
- et al.
Results
Study inclusion

Characteristics of included studies
Study design, participants, and quality appraisal
Study (country), design, quality, attrition | Participants | Descriptions of Interventions | Outcomes, follow-up | Conclusion |
---|---|---|---|---|
Cunningham et al. 18 (UK) RCT High quality 3% | Total n = 58, IC in at least one leg Post-exercise ABI < 0.7 | Intervention: Usual care + Information on PAD and walking, motivational interviewing, PA goal setting, action planning, self monitoring and feedback, barrier identification with problem solving. Delivered at patients' homes by via a trainee health psychologist 2 × 1 h sessions Control: Usual care (walking advice + consultation with vascular surgeon) | Daily steps (pedometer) Walking ability (patient report) ICQ (disease specific quality of life) Medical Outcome Study Short-Form (generic health related quality of life) Outcomes assessed at baseline and 4 months | Brief psychological intervention significantly improved walking behaviour in patients with IC in comparison with usual care |
Tew et al. 19 (UK)Pilot RCT High quality 4.35% | Total n = 23 Stable Rutherford IC Classification 1–3 for ≥ 3 months | Intervention: Usual care plus one off 3 h session of group patient centred structured education including patient story, PAD/IC and walking information provision, PA feedback, barrier identification with problem solving, goal setting, action planning, and self monitoring. Delivered at in clinical research facility followed by twice-weekly phone calls for 6 weeks. Control: Usual care | Daily step (accelerometer) ICD, 6 minute walk test WELCH questionnaire ICQ (disease specific quality of life) EQ-5D (generic health related quality of life) Self efficacy Acceptability (exit interview) Outcomes assessed at baseline and 6 weeks | Education programme is feasible, acceptable, and potentially useful for improving walking capacity and quality of life |
Fowler et al. 20 (Australia)RCT High quality 15% | Total n = 882 ABI ≤ 0.9 Clinical diagnosis of PAD Definite IC or atypical IC on Edinburgh Claudication Questionnaire | Intervention: Educational package + mobility program (supervised or home based) + smoking cessation where applicable Control: No intervention | ICD PA pattern (Patient report) Medical Outcome Study Short-Form (generic health related quality of life) Outcomes assessed at baseline, 2 months, and 12 months | Intervention for early PAD based on increased PA and smoking cessation results in a greater max walking distance 12 months later |
Collins et al. 21 (USA)Pilot RCT Low quality 13.7% | Total n = 51, Diagnosis of PAD ABI > 0.5 and ≤ 0.955. | Intervention: Communication intervention beginning with completion of guide and followed by 15–20 minute of motivational interviewing, provision of information related to PAD/IC and walking, barrier identification and problem solving strategies, patient tailored walking prescription. Delivered by medical student Control: Video Intervention | PA pattern and time (patients report) ICD and ACD WIQ Outcomes assessed at baseline, and 12 weeks | Patients watching video on the use of PA in PAD improved participants walking speed |
Prevost et al. 23 (France)Pre-test–post-test design Low quality 4.17% | Total n = 48 Level II Leriche and Fontaine IC Atypical symptom ABI < 0.9 | Intervention: Educational classes, implementation of secondary prevention, and a personalised program of reconditioning exercises Control: No intervention | ICD and ACD Medical Outcome Study Short-Form (generic health related quality of life) Pain intensity Patients experiences via exit questionnaire (12 months only) Outcomes assessed at baseline, 3 months and 12 months | Educational therapeutic program results in a significant improvement in functional and QoL parameters during the first 3 months in patients with IC and persists even patients are no longer coached |
Mays et al. 22 (USA)Pilot RCT High quality 20% | Total n = 25 Patients without walking limiting comorbidities except IC Severe cardiac ischaemia ≤ 3 months previous myocardia infarction TIA or stroke < 1 month treatment with cilostazol or penthoxifylline Endovascular therapy 4–6 weeks prior baseline or stable IC without revascularisation in the last 4–6 weeks (ABI ≤ 0.9) | Intervention: Initial in hospital walking exercise (2 weeks, 3 days/week) followed by community based walking exercise (12 weeks) with training, monitoring and coaching (TMC) components. Control: Usual care (standard advice to walk) | ICD and ACD WIQ Medical Outcome Study Short-Form (generic health related quality of life) Outcomes assessed at baseline and 14 weeks | Community based walking exercise with TMC improves ICD and walking performances other than ACD |
Authors | Sources/Potential sources of bias | Summary of risk of bias | Quality index | ||||||
---|---|---|---|---|---|---|---|---|---|
Selection bias | Performance bias | Detection bias | Bias due to attrition | Reporting bias | Other bias | ||||
Random sequence generation | Allocation concealment | Participants and personnel blinding | Blinding of outcome assessments | Incomplete outcome data | Selective reporting | ||||
Cunningham et al. 18 | No | Yes | No | Yes | No | No | Trial was not powered | Low | High |
Tew et al. 19 | No | No | No | No | Yes | No | Pilot study | Low | High |
Fowler et al. 20 | No | No | No | Yes | No | No | NA | Low | High |
Collins et al. 21 | No | Yes | Yes | Yes | No | No | Pilot study | High | Low |
Prevost et al. 23 | Yes | Yes | Yes | Yes | No | No | NA | High | Low |
Mays et al. 22 | No | No | Yes | Yes | No | No | Pilot study | Low | High |
Authors | Change in daily PA behaviour | PA capacity/ability measures | Pain, self efficacy, and perceived control over illness | Quality of life |
---|---|---|---|---|
Mays et al. 22 | At 14 weeks: Pain free walking time (p = NS); Greater increase in claudication onset time (5.8 ± 1.5 min to 7.4 ± 1.6 min vs. 4.7 ± 1.4 min →4.1 ± 1.5 min; p = 0.045); Greater improvement in walking impairment (42.3 ± 7.7 min →60.6 ± 7.2% vs. 49.1 ± 7.7 →44.6 ± 7.2%; p = 0.001) | At 14 weeks: General QoL (p = NS) | ||
Prevost et al. 23 | Significant % increase in ICD from baseline (277% at 3 months, 203% @ 6 months, 141% @ 12 months; p < 0.001) Significant % increase in ACD from baseline (63% @ 3 months; 84% @ 6 months; 65% @ 12 months; p < 0.01) | Decrease in pain intensity at 3, 6, 12 months from baseline (5.89→4.73→4.34** →4.53) Improved from baseline in time of release of pain at 6 months, and 12months (3.95 →2.01** →2.83**) | Improvement from baseline in physical composite score of SF-36 at 3, 6, and 12 months (36.0→40.8→41.9→42.9; p < 0.01) Improvement from baseline in the mental composite of SF-36 at 3 and 6 months (41.6→45.5→44.7→44.2; p < 0.05) | |
Cunningham et al. 18 | At 4 months: Greater increase in daily steps (1358 vs. −227; p < 0.001) | At 4 months: Greater pain free walking distance (1.00 vs. 0.00; p = 0.008) | At 4 months: Improvement in general QoL (0.40 vs. −0.30; p = 0.002) Disease specific QoL (p=NS) | |
Tew et al., 2015 19 | At 6 weeks: Daily steps (p=NS) | At 6 weeks: Improvement in Six minute walk distance (44.9; CI 6.9 to 82.9); Greater increase in ACD (173; CI 23 to 322); ICD p=NS Greater improvement in self reported walking ability WELCH score (21.8; CI 8.6 to 35.0); WIQ Speed (21.0; CI 3.8 to 38.1), WIQ distance (30.7; CI 6.4 to 55.0), WIQ stair climbing (30.7; CI 6.4 to 55.0) | At 6 weeks: Improvement in walking performance efficacy (29.5; CI 12.6 to 46.4) Greater improvement in perceive control over illness (2.4; CI 0.0 to 4.7) | At 6 weeks: Greater improvement in disease specific QoL (−10.6; CI –18.9 to −2.3) General QoL (p = NS) |
Fowler et al., 2002 20 | At 2 months: % of patients walking for recreation ≥ 3/week (p=NS); % of patients engaging in vigorous PA (p=NS); % of patient belonging to exercise group (p=NS) At 12th month: Greater % of patient walking for recreation ≥ 3/week (33.8 vs. 25; p = 0.01); % of patients engaging in vigorous PA (p = NS); Greater % of belonging to exercise group (16.5 vs. 1.8, p < 0.001) | At 2 months: Self report maximum walking distance before the onset of pain (p = NS) At 12th month: Improvement in self report maximum walking distance before the onset of pain (p = 0.04) | At 2 months: HQoL(NS) At 12th month HQoL(NS | |
Collins et al. 2009 21 | At 12 weeks: Activity patterns in various levels of physical activity (p=NS) |
Components of interventions in included studies
Outcomes reported in included studies
Effect of interventions in included studies
Daily physical activity outcomes
Self report daily physical activity outcome
Objectively measured daily physical activity outcome
Walking capacity
Quality of life and other outcomes
Patient experiences with interventions
Category label | Category description |
---|---|
Receiving information about disease | Participants valued participation in the intervention because it provided them with greater understanding of their condition (T); Patient valued intervention because it provided them with extra information about their illness(C). 97% were very satisfied with the topic discussed (P) |
Receiving information about walking | Patients reported that they valued the intervention because it provided them with understanding of the importance of walking(C); Patients reported that they valued the intervention because it provided them with understanding of how walking will help(C); Patient said intervention were worthwhile and that they valued it because it provided them with extra information about walking (C) |
Being motivation and empowered | Patients reported being satisfied with their improvement in attitude towards walking with their claudication and their physical self confidence (P); Patients reported being satisfied with their improvement in their physical self confidence (P); Participants valued participation because it enabled them to walk more (T); Patients said they valued intervention because it provided them with extra encouragement and motivation(C) |
Benefit of group education session | 97% reported that they were very satisfied with the benefit of group education session (P) |
Self monitoring | The use of pedometer was valued as it was seen as useful tool for self monitoring (T) |
Goal setting | Patient reported that intervention were worthwhile because it provided them clarity on what to do (C); |
Pedometer as useful tool | Patients valued the pedometer and seen as a valuable tool for motivation, self monitoring, and goal setting (T) |
Receiving personalised care | 95.5% reported very satisfied with the scope, quality, and benefit of individual discussion (P); patients valued the intervention because it provided personalised plan(C) |
Synthesised finding | Category |
---|---|
Acquiring knowledge | Receiving information about disease; receiving information about for walking; goal setting; pedometer as useful tool |
Pragmatic and tailored care | Benefit of group education session; receiving personalised care |
Gaining confidence and self monitoring | Being motivation and empowered; pedometer as useful tool; self monitoring; pedometer as useful tool |
Acquiring knowledge
Receiving pragmatic and tailored care
Gaining confidence and self monitoring
Discussion
Department of Health, Diabetes UK. Structured patient education in diabetes: Report from the Patient Education Working Group 2005. Retrieved October 10, 2016, from https://www.diabetes.org.uk/Documents/Reports/StructuredPatientEd.pdf.
- Moher D.
- Shamseer L.
- Clarke M.
- Ghersi D.
- Liberati A.
- Petticrew M.
- et al.
Funding
Conflict of Interest
References
- Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia.Circ Res. 2015; 116: 1540-1550
- Premature peripheral arterial disease – difficult diagnosis in very early presentation.Int J Angiol. 2009; 18: 45-47
- Peripheral arterial disease: considerations in risks, diagnosis, and treatment.J Natl Med Assoc. 2009; 101: 999-1008
- Lack of exercise is a major cause of chronic diseases.Compr Physiol. 2012; 2: 1143-1211
- The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program.Vasc Med. 2008; 13: 15-24
National Institute for Health and Care Excellence. NICE Peripheral arterial disease quality standard 2014. Retrieved June 12, 2016, from https://www.nice.org.uk/guidance/qs52/resources/peripheral-arterial-disease-20987238166458.
- Supervised exercise therapy versus nonsupervised exercise therapy for intermittent claudication.Cochrane Database Syst Rev. 2013; 8: CD005263
- The effect of supervised exercise therapy on physical activity and ambulatory activities in patients with intermittent claudication.Eur J Vasc Endovasc Surg. 2015; 49: 184-191
- Physical activity during daily life and mortality in patients with peripheral arterial disease.Circulation. 2006; 114: 242-248
- Barriers to physical activity in patients with intermittent claudication.Int J Behav Med. 2015; 22: 70-76
- Standing still in the street’’: experiences, knowledge and beliefs of patients with intermittent claudication—a qualitative study.J Vasc Nurs. 2015; 33: 4-9
Department of Health, Diabetes UK. Structured patient education in diabetes: Report from the Patient Education Working Group 2005. Retrieved October 10, 2016, from https://www.diabetes.org.uk/Documents/Reports/StructuredPatientEd.pdf.
- Patient education interventions to improve physical activity in patients with intermittent claudication: a protocol for systematic review.BMJ Open. 2016; 6: e011405
Cochrane Consumers and Communication Review Group. Communication review group: Data extraction template for Cochrane reviews. Cochrane Collaboration, 2007 (Updated Dec 2016). http://cccrg.cochrane.org/author-resources. [Accessed 10 May 2017].
Noyes J, Lewin S. Extracting qualitative evidence. In: Noyes J, Booth A, Hannes K, Harden A, Harris J, Lewin S, Lockwood C (Eds.), Supplementary guidance for inclusion of qualitative research in Cochrane systematic reviews of interventions, Chapter 5. Version 1 (updated August 2011). Cochrane Collaboration Qualitative Methods Group, 2011. Retrieved April 27, 2017, from http://cqrmg.cochrane.org/supplemental-handbook-guidance.
- Cochrane handbook for systematic reviews of interventions.(Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration, 2011. Retrieved April 27, 2017, from)2014
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.Syst Rev. 2015; 4https://doi.org/10.1186/2046-4053-4-1
- Randomized clinical trial of a brief psychological intervention to increase walking in patients with intermittent claudication.Br J Surg. 2012; 99: 49-56https://doi.org/10.1002/bjs.7714
- The development and pilot randomised controlled trial of a group education programme for promoting walking in people with intermittent claudication.Vasc Med. 2015; 20: 348-357
- Improving maximum walking distance in early peripheral arterial disease: randomised controlled trial.Aust J Physiother. 2002; 48: 269-275
- Face-to-face interaction compared with video watching on use of physical activity in peripheral arterial disease: a pilot trial.Angiol. 2009; 60: 21-30
- Community-based walking exercise for peripheral artery disease: an exploratory pilot study.Vasc Med. 2015; 20: 339-347
- Education and home based training for intermittent claudication: functional effects and quality of life.Eur J Prev Cardiol. 2015; 22: 373-379
- Do behaviour-change techniques contribute to the effectiveness of exercise therapy in patients with intermittent claudication? A systematic review.Eur J Vasc Endovasc Surg. 2013; 46: 132-141
- Systematic review of home-based exercise programmes for individuals with intermittent claudication.Eur J Vasc Endovasc Surg. 2013; 46: 690
Article info
Publication history
Identification
Copyright
User license
Elsevier user license |
Permitted
For non-commercial purposes:
- Read, print & download
- Text & data mine
- Translate the article
Not Permitted
- Reuse portions or extracts from the article in other works
- Redistribute or republish the final article
- Sell or re-use for commercial purposes
Elsevier's open access license policy
ScienceDirect
Access this article on ScienceDirectRelated Articles
Comments
Commenting Guidelines
To submit a comment for a journal article, please use the space above and note the following:
- We will review submitted comments as soon as possible, striving for within two business days.
- This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
- We require that commenters identify themselves with names and affiliations.
- Comments must be in compliance with our Terms & Conditions.
- Comments are not peer-reviewed.